Skip to main content

Table 1 Baseline characteristics of patients completing the study a

From: Trapa bispinosa Roxb. extract lowers advanced glycation end-products and increases live births in older patients with assisted reproductive technology: a randomized controlled trial

Characteristic (unit)

Hishi group (n = 32)

Control group (n = 31)

Age (year)

38.9 ± 1.0

39.1 ± 0.9

Infertility duration (years)

2.8 ± 2.9

2.2 ± 2.3

Number of previous ART attempts

0.5 ± 0.7

0.2 ± 0.5

Gravidity

0.9 ± 1.0

1.1 ± 1.6

Parity

0.4 ± 0.6

0.4 ± 0.6

Body mass index (BMI, kg/m2)

21.6 ± 2.5

21.0 ± 2.3

Systolic / diastolic blood pressure (mm Hg)

108 ± 14 / 66 ± 8.4

108 ± 11 / 67 ± 7.7

Anti-Müllerian hormone (ng/mL)

2.96 ± 2.36

3.97 ± 4.25

Follicle-stimulating hormone on day 3 (IU/L)

6.8 ± 2.3

7.0 ± 3.0

Luteinizing hormone on day 3 (IU/L)

4.2 ± 1.9

4.9 ± 2.3

Prolactin (ng/mL)

9.8 ± 5.9

11.3 ± 8.9

Estradiol on day 3 (pg/mL)

49 ± 50

79 ± 108

Testosterone on day 3 (ng/mL)

0.19 ± 0.09

0.27 ± 0.43

Fasting plasma glucose (FPG, mg/dL)

81.8 ± 7.7

81.3 ± 7.0

Fasting serum insulin (FSI, μU/mL)

4.5 ± 1.9

4.1 ± 1.3

Hemoglobin A1c (%)

5.3 ± 0.2

5.2 ± 0.2

HOMA-Rb (μUg/dL2)

0.93 ± 0.44

0.83 ± 0.28

Insulinogenic index (II, dU/g)

1.02 ± 1.62

0.62 ± 3.02

Total cholesterol (TC, mg/dL)

198 ± 32

184 ± 29

Low-density lipoprotein cholesterol (LDL, mg/dL)

112 ± 24

99 ± 33

Triglycerides (TG, mg/dL)

71 ± 51

61 ± 24

Uric acid (UA, mg/dL)

4.3 ± 1.0

4.1 ± 0.7

  1. aNo significant differences were found between groups (Unpaired t test for BMI, systolic / diastolic blood pressure, FPG, FSI, and UA; Mann-Whitney U test for other charasteristics)
  2. bHomeostasis model assessment-insulin resistance index